These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 10721812)

  • 21. Ischemic modulation of vulnerable period and the effects of pharmacological treatment of ischemia-induced arrhythmias: a simulation study.
    Cimponeriu A; Starmer CF; Bezerianos A
    IEEE Trans Biomed Eng; 2003 Feb; 50(2):168-77. PubMed ID: 12665030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative studies on the anti-arrhythmic and anti-fibrillatory effectiveness of verapamil and nifedipine following acute coronary artery occlusion and reperfusion].
    Gülker H; Thale J; Brisse B; Bender F
    Z Kardiol; 1984 Aug; 73(8):515-24. PubMed ID: 6495811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electrophysiological effects of flecainide and sotalol in the human atrium during persistent atrial fibrillation.
    Kirchhof P; Engelen M; Franz MR; Ribbing M; Wasmer K; Breithardt G; Haverkamp W; Eckardt L
    Basic Res Cardiol; 2005 Mar; 100(2):112-21. PubMed ID: 15696400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiarrhythmic properties of tetrodotoxin against occlusion-induced arrhythmias in the rat: a novel approach to the study of the antiarrhythmic effects of ventricular sodium channel blockade.
    Abraham S; Beatch GN; MacLeod BA; Walker MJ
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1166-73. PubMed ID: 2557414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Negative dromotropic effects of class I antiarrhythmic drugs in anisotropic ventricular muscle.
    Iida M; Kodama I; Toyama J
    Cardiovasc Res; 1996 Apr; 31(4):640-50. PubMed ID: 8689657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Class Ic antiarrhythmic drugs and myocardial ischaemia: study in the pig heart in situ.
    Timour Q; Aupetit JF; Loufoua-Moundanga J; Gerentes-Chassagne I; Kioueh I; Faucon G
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jun; 343(6):645-51. PubMed ID: 1944606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glibenclamide does not prevent action potential shortening induced by ischemia in anesthetized rabbits but reduces ischemia-induced arrhythmias.
    Barrett TD; Walker MJ
    J Mol Cell Cardiol; 1998 May; 30(5):999-1008. PubMed ID: 9618240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ivabradine induces an increase in ventricular fibrillation threshold during acute myocardial ischemia: an experimental study.
    Vaillant F; Timour Q; Descotes J; Manati W; Belhani D; Bui-Xuan B; Tabib A; Bricca G; Chevalier P
    J Cardiovasc Pharmacol; 2008 Dec; 52(6):548-54. PubMed ID: 19034029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heart rate reduction with ivabradine increases ischaemia-induced ventricular fibrillation threshold: role of myocyte structure and myocardial perfusion.
    Vaillant F; Dehina L; Mazzadi A; Descotes J; Chevalier P; Tabib A; Bui-Xuan B; Riera C; Belhani D; Timour Q
    Resuscitation; 2011 Aug; 82(8):1092-9. PubMed ID: 21561702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Current classification of anti-arrhythmia agents].
    Weirich J; Wenzel W
    Z Kardiol; 2000; 89 Suppl 3():62-7. PubMed ID: 10810787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism of flecainide's rate-dependent actions on action potential duration in canine atrial tissue.
    Wang Z; Fermini B; Nattel S
    J Pharmacol Exp Ther; 1993 Nov; 267(2):575-81. PubMed ID: 8246130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potent antifibrillatory effect of combined blockade of calcium channels and 5-HT2 receptors with nexopamil during myocardial ischemia and reperfusion in dogs: comparison to diltiazem.
    Nearing BD; Hutter JJ; Verrier RL
    J Cardiovasc Pharmacol; 1996 Jun; 27(6):777-87. PubMed ID: 8761843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antifibrillatory effects of class III antiarrhythmic drugs: comparative study with flecainide.
    Usui M; Inoue H; Saihara S; Sugimoto T
    J Cardiovasc Pharmacol; 1993 Mar; 21(3):376-83. PubMed ID: 7681497
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of asynchronous activation of the ventricular fibres by an ectopic pacemaker in the accidents, especially fibrillation, caused by Ic antiarrhythmic drugs.
    Timour Q; Aupetit JF; Loufoua-Moundanga J; Kioueh I; Omar S; Chevrel G; Faucon G
    Fundam Clin Pharmacol; 1992; 6(4-5):159-67. PubMed ID: 1427561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reperfusion-induced ventricular fibrillation. Modification by pharmacological agents.
    Manning AS; Crome R; Isted K; Coltart DJ; Hearse DJ
    Adv Myocardiol; 1985; 6():515-28. PubMed ID: 2581300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Possible prevention by amlodipine of ventricular fibrillation related to brief ischemia episodes.
    Timour Q; Aupetit JF; Freysz M; Frassati D; Faucon G
    Can J Physiol Pharmacol; 1996 Dec; 74(12):1308-14. PubMed ID: 9047040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diabetes mellitus reduces the antiarrhythmic effect of ion channel blockers.
    Ito I; Hayashi Y; Kawai Y; Iwasaki M; Takada K; Kamibayashi T; Yamatodani A; Mashimo T
    Anesth Analg; 2006 Sep; 103(3):545-50. PubMed ID: 16931659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Asocainol, a new antiarrhythmic drug with natrium- and calcium-antagonistic effects on ventricular myocardium.
    Späh F
    J Cardiovasc Pharmacol; 1984; 6(6):1027-35. PubMed ID: 6084758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Preventive antifibrillatory treatment of sudden cardiac death in acute myocardial infarct].
    Thale J; Gülker H; Hindricks G; Haverkamp W; Pollock B; Buchwalsky R
    Z Kardiol; 1988; 77 Suppl 4():11-22. PubMed ID: 3062962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.